Haynes and Boone, LLP represented Alliqua BioMedical, Inc. in a $29 million asset purchase agreement with Celularity, Inc. The agreement, which is subject to stockholder approval,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
